• Explore /
  • Poster
  • / Immune-related adverse events (irAE) to cancer immune checkpoint inhibitors (CPI) and survival outcomes: To rechallenge or not–An Appalachian institution’s experience.

Immune-related adverse events (irAE) to cancer immune checkpoint inhibitors (CPI) and survival outcomes: To rechallenge or not–An Appalachian institution’s experience.

Abstract Poster

Authors

null

Heidar Albandar

West Virginia University, Mary Babb Randolph Cancer Center, Morgantown, WV

Heidar Albandar, Salah Ud Din Safi, Jacob Lane Fuqua, Samuel Merrill, Patrick C. Ma

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies

Sub Track

Immune Checkpoints and Stimulatory Receptors

Citation

J Clin Oncol 38, 2020 (suppl 5; abstr 81)

Abstract #

81

Poster Bd #

B2

Abstract Disclosures

Similar Posters

First Author: Vincenzo Quagliariello

Poster

2023 ASCO Annual Meeting

Cardiotoxicity surveillance among patients with cancer treated with immunotherapy.

Cardiotoxicity surveillance among patients with cancer treated with immunotherapy.

First Author: Juliana Goes Martins Fagundes

First Author: Michael Offin

First Author: Laura A Petrillo